GKOS PEER ANALYSIS

Glaukos Corp — metric-by-metric comparison with peers and the industry median

GKOSGlaukos Corp

🇺🇸 USA · NYSE · Healthcare · Medical Devices

Value it Duel

Overall Profile & Returns

· Medical Devices

Position Within Industry

0 = weak quartile, 100 = strong quartile

GKOSIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	GKOS	COH	PHIA	SHL	4DX	SN	Ind. Median
P/E	—	23.72	24.65	18.77●	—	20.56	27.44
P/B	12.83	4.23	2.10	2.16	-74.16●	2.48	2.48
EV/EBITDA	—	14.87	10.82	11.97	—	9.88●	15.23
P/S	15.61	3.47	1.36●	1.70	243.16	2.09	2.66

Financial Health
Metric	GKOS	COH	PHIA	SHL	4DX	SN	Ind. Median
Current Ratio	5.43	2.46	1.32	1.10	6.57●	2.57	3.28
Debt/Equity	15.4%	22.1%	71.1%	84.1%	-22.6%●	62.9%	44.7%
NetDebt/EBITDA	1.21	0.42●	2.03	3.04	0.71	1.72	0.82

Profitability
Metric	GKOS	COH	PHIA	SHL	4DX	SN	Ind. Median
Net Margin	-34.3%	14.6%●	5.5%	9.1%	-3,684.6%	10.1%	-5.7%
ROE	-26.4%	18.1%●	8.4%	11.4%	—	12.1%	-8.6%
ROA	-20.4%	12.4%●	3.6%	4.6%	-264.3%	6.1%	-6.4%
EBITDA Margin	-26.1%	24.0%	15.4%	19.1%	-818.8%	25.6%●	5.2%

Growth + Dividend
Metric	GKOS	COH	PHIA	SHL	4DX	SN	Ind. Median
Rev. Growth	36.3%●	2.0%	-1.9%	-0.3%	-26.0%	—	7.4%
NI Growth	—	-6.8%	160.1%●	0.3%	—	—	16.7%
Div. Yield	—	3.6%●	3.5%	2.9%	—	3.5%	1.1%
Payout	—	81.5%	33.8%	48.4%	—	52.8%	39.0%

Valuation
Metric	GKOS	BIO	BRKR	MASI	GMED	PODD	Ind. Median
P/E	—	47.41	—	124.05	18.87●	38.13	27.44
P/B	12.83	1.17●	3.84	12.00	2.34	8.86	2.48
EV/EBITDA	—	16.64	36.18	28.52	12.00●	20.89	15.23
P/S	15.61	3.09	2.72●	6.07	3.57	3.98	2.66

Financial Health
Metric	GKOS	BIO	BRKR	MASI	GMED	PODD	Ind. Median
Current Ratio	5.43●	3.21	1.55	2.68	4.56	2.49	3.28
Debt/Equity	15.4%	20.1%	68.2%	61.6%	2.4%●	72.8%	44.7%
NetDebt/EBITDA	1.21	-0.40	5.08	1.05	-0.58●	0.81	0.82

Profitability
Metric	GKOS	BIO	BRKR	MASI	GMED	PODD	Ind. Median
Net Margin	-34.3%	6.5%	-0.3%	4.9%	18.9%●	10.4%	-5.7%
ROE	-26.4%	2.5%	-0.5%	8.8%	13.3%	23.0%●	-8.6%
ROA	-20.4%	1.7%	-0.2%	3.9%	11.6%●	9.3%	-6.4%
EBITDA Margin	-26.1%	18.1%	8.8%	22.1%	28.4%●	19.8%	5.2%

Growth + Dividend
Metric	GKOS	BIO	BRKR	MASI	GMED	PODD	Ind. Median
Rev. Growth	36.3%●	1.9%	0.4%	-14.4%	23.5%	31.9%	7.4%
NI Growth	—	—	—	—	216.2%●	-24.7%	16.7%
Div. Yield	—	1.0%●	0.3%	—	—	—	1.1%
Payout	—	46.4%	-377.6%	—	—	—	39.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on GKOS

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.